LH insider files Form 144 to sell restricted shares

LH filed a Form 144 reporting proposed sales of common stock tied to restricted stock vesting.

Accepted by SEC EDGAR 02/24/2026 - 01:50 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

LH filed a Form 144 reporting proposed sales of common stock tied to restricted stock vesting. The notice lists planned vesting-related dispositions including 458 shares vested 02/06/2025, 447 shares vested 02/07/2025, 66 shares vested 02/11/2025, and 529 shares vested 02/11/2026. The transactions are described as issuer restricted stock vesting.

Insights

Corporate Governance Counsel

Form 144 lists specific restricted-stock vesting events and planned dispositions by the holder.

The notice identifies four discrete vesting-related common share amounts: 458, 447, 66, and 529 with associated vesting dates in 2025 and 2026

These entries reflect routine insider sales following vesting; timing and execution details are not provided in the excerpt, and cash-flow treatment is not stated in the provided text.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does LH's Form 144 report about restricted stock?

It reports planned dispositions of common shares tied to restricted stock vesting. The filing lists 458, 447, 66, and 529 shares with vesting dates in 02/06/2025, 02/07/2025, 02/11/2025, and 02/11/2026.

Does the Form 144 state when LH shares will be sold?

The excerpt lists vesting dates for the restricted shares but does not state execution timing. It shows vesting on 02/06/2025, 02/07/2025, 02/11/2025, and 02/11/2026; sale execution details are not included in the provided text.

Who is identified as the broker or custodian in the LH Form 144?

Fidelity Brokerage Services LLC is listed in the filing. The entry shows an address at 900 Salem Street, Smithfield, RI and references NYSE-related handling in the provided excerpt.

Do the listed share amounts in LH's Form 144 represent total holdings?

They represent specific restricted-share vesting amounts listed for sale, not an aggregate holding total. The filing cites separate vesting quantities of 458, 447, 66, and 529 on the stated dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001717915
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LABCORP HOLDINGS INC.
SEC File Number	001-11353
Address of Issuer	358 S MAIN ST BURLINGTON NORTH CAROLINA 27215
Phone	3362291127
Name of Person for Whose Account the Securities are To Be Sold	Caveney Brian J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1500	429457.50	82900000	02/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/06/2025	Restricted Stock Vesting	Issuer			458	02/06/2025	Compensation
Common	02/07/2025	Restricted Stock Vesting	Issuer			447	02/07/2025	Compensation
Common	02/11/2025	Restricted Stock Vesting	Issuer			66	02/11/2025	Compensation
Common	02/11/2026	Restricted Stock Vesting	Issuer			529	02/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brian J. Caveney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)